Evaluation of platelet transfusion thresholds in patients with acute myeloblastic leukemia receiving induction chemotherapy

Internal Medicine

Volumn 46, Issue 19, 2007, Pages 1669-1670

  Oka, Satoko ^a   Muroi, Kazuo ^a   Mori, Masaki ^a   Matsuyama, Tomohiro ^a   Fujiwara, Sin Ichiro ^a   Oh, Iekuni ^a   Ono, Yoko ^a   Kikuchi, Satoru ^a   Sato, Kazuya ^a   Ueda, Masuzu ^a   Toshima, Masaki ^a   Ozaki, Katsutoshi ^a   Takatoku, Masaaki ^a   Nagai, Tadashi ^a   Ozawa, Keiya ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

AML; Induction; Platelet count; Platelet transfusion

Indexed keywords

ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; THROMBOCYTE CONCENTRATE;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BONE MARROW SUPPRESSION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; UNIVERSITY HOSPITAL; ACUTE GRANULOCYTIC LEUKEMIA; CHEMICALLY INDUCED DISORDER; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; GUIDELINES; HEMORRHAGE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PLATELET TRANSFUSION; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 35448981824     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0345     Document Type: Article

References (6)

1. Platelet transfusion therapy. National Institutes of Health Consensus Conference. Transfus Med Rev 1: 195-200, 1987.
2. Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med 337: 1870-1875, 1997.
3. Heckman KD, Weiner GJ, Davis CS, et al. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. J Clin Oncol 15: 1143-1149, 1997.
4. Wandt H, Frank M, Ehninger G, et al. Safety and cost effectiveness of a 10 × 10 (9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 × 10 (9)/L trigger:a prospective, comparative trial in 105 patients with acute myeloid leukemia. Blood 91: 3601-3606, 1998.
5. Suzuki A, Ohyashiki K, Kimura Y, et al. for the Japan Adult Leukemia, Study Group. Trisomy 11 acute myeloid leukemia: 5 additional cases from the Japan Aduly Leukemia Study Group AML-92 and AML-95 databases. Int J Hematol 72: 466-469, 2000.
6. Kobayashi T, Miyawaki S, Tanimoto M, et al. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/ intensification, therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group. J Clin Oncol 14: 204-213, 1996.